Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SOCS2 contributors: mct - updated : 08-02-2016
HGNC name suppressor of cytokine signaling 2
HGNC id 19382
DNA
TYPE functioning gene
STRUCTURE 6.00 kb     3 Exon(s)
10 Kb 5' upstream gene genomic sequence study
MAPPING cloned Y linked   status confirmed
RNA
TRANSCRIPTS type messenger
EXPRESSION
Type widely
constitutive of
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Cardiovascularheart    
Digestiveliver    
Endocrineparathyroid   highly
Reproductivemale systemprostate  highly
Urinarykidney    
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Blood / hematopoieticbone marrow  highly
Connectiveadipose  highly
cells
SystemCellPubmedSpeciesStageRna symbol
Endocrineislet cell (alpha,beta...)
cell lineage hematopoietic cell lineages
cell lines
fluid/secretion
at STAGE
physiological period fetal, pregnancy
Text placenta, kidney
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • solitary Src homology SH2 domain
  • conserved SOCS-box motif being essential for all inhibitory function
  • a C terminal SOCS, CIS (CH domain) sequence
  • HOMOLOGY
    Homologene
    FAMILY suppressor of cytokine signaling (SOCS) or STAT-induced STAT inhibitor (SSI), protein family
    CATEGORY regulatory , signaling cytokine
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm
    intracellular,nucleus
    text localization regulated by cellular conditions (nuclear localization being stimulated by conditions that increased cytoplasmic protein levels)
    basic FUNCTION
  • involved in the interleukin-6 induced receptor phosphorylation and in the negative regulation of cytokine induced STAT factor signaling
  • regulating protein turnover, targeting proteins for proteasome-mediated degradation
  • may acting either as an enhancer or suppressor of growth hormone signaling
  • negative regulator of GH signaling
  • SOCS2 is an ubiquitin ligase for the GHR unveils the molecular basis for its physiological actions
  • SOCS2 associates with activated FLT3 and negatively regulates the FLT3 signaling pathways
  • CELLULAR PROCESS cell life, proliferation/growth
    protein, degradation
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • binding and regulating activated insulin-like growth factor receptor 1 (IGF1R)
  • mediating estrogen inhibition of GH1 signaling
  • binding the erythropoietin receptor
  • bind 2 phosphorylated tyrosines on the GH receptor
  • interaction with ELOB/ELOC controls SOCS2 protein turnover and affects its molecular activity
  • SOCS2 negatively regulates FLT3 signaling by blocking activation of Erk 1/2 and STAT5
  • SOCS2-interacting protein, and binding requires the SOCS2 SH2 domain and EPHA2 activation loop autophosphorylation, which is stimulated by EFNA1 or by phosphotyrosine phosphatase inhibition
  • cell & other
    REGULATION
    induced by EPO,CSF2
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Susceptibility
  • to asthma and atopy
  • to type 2 diabetes
  • Variant & Polymorphism SNP increasing the risk of type 2 diabetes
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS
    promoting mouse neural development by blocking growth hormone mediated downregulation of neurogenin